High-affinity glycine and glutamate transport in pig forebrain white and gray matter: a quantitative study.
High-affinity uptake of glycine and glutamate modulates glutamatergic neurotransmission in gray matter. N-Methyl-D-aspartate (NMDA) receptors were recently described on white matter oligodendrocytes, therefore uptake of glutamate and glycine in white matter may also modulate NMDA receptor function. We found that glycine uptake in white structures of pig forebrain (corpus callosum, fimbria, subcortical pyramidal tracts, and occipital subcortical white matter) was similar to that in gray structures (frontal and temporal cortices and hippocampus), and that it was sensitive to sarcosine, a GLYT1 inhibitor (IC(50) 15 microM). Glutamate uptake in white matter was approximately 10% of that in gray; it was sensitive to dihydrokainate, an EAAT2 inhibitor. The levels of glycine and its precursor serine were similar in white and gray matter: approximately 2 and 1 nmol/mg tissue, respectively. The white matter level of glutamate was approximately 7.6 nmol/mg tissue, or approximately 74% of gray matter levels. The activity of serine hydroxymethyl transferase, which converts serine into glycine, was similar in white and gray matter (11-18 pmol/(mg tissue)min), whereas the white matter activity of phosphate-activated glutaminase, which converts glutamine into glutamate, was approximately 100 pmol/(mg tissue)min, or approximately 34% of gray matter activity. The white matter activity of glutamine synthetase, the glial enzyme that converts glutamate into glutamine, was 20-40 nmol/(mg tissue)min in neocortex and 5-6 nmol/(mg tissue)min in white matter. The data show that forebrain white matter is equipped to regulate extracellular levels of glycine and glutamate, functions that may modulate white matter NMDA receptor function.
Henjum
Solveig
S
Norwegian Defence Research Establishment, 2027 Kjeller, Norway.
Hassel
Bjørnar
B
D000818:Animals; D001692:Biological Transport / Q000187:drug effects; D027342:Excitatory Amino Acid Transporter 2 / Q000037:antagonists & inhibitors; D005974:Glutamate-Ammonia Ligase / Q000378:metabolism; D018698:Glutamic Acid / Q000378:metabolism*; D005972:Glutaminase / Q000378:metabolism; D005973:Glutamine / Q000378:metabolism; D005978:Glutathione / Q000378:metabolism; D005998:Glycine / Q000378:metabolism*; D012696:Glycine Hydroxymethyltransferase / Q000378:metabolism; D050487:Glycine Plasma Membrane Transport Proteins / Q000037:antagonists & inhibitors; D007608:Kainic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D016548:Prosencephalon / Q000378:metabolism*; D012521:Sarcosine / Q000494:pharmacology; D012694:Serine / Q000378:metabolism; D013552:Swine
D027342:Excitatory Amino Acid Transporter 2; D050487:Glycine Plasma Membrane Transport Proteins; D005973:Glutamine; D018698:Glutamic Acid; D012694:Serine; C020889:dihydrokainic acid; D012696:Glycine Hydroxymethyltransferase; D005972:Glutaminase; D005974:Glutamate-Ammonia Ligase; D005978:Glutathione; D007608:Kainic Acid; D005998:Glycine; D012521:Sarcosine